Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases

被引：39
|
作者：
Valente, Sergio [1 ]
Bana, Emilie [1 ]
Viry, Elodie [1 ]
Bagrel, Denyse [1 ]
Kirsch, Gilbert [1 ]
机构：
[1] Univ Paul Verlaine, Lab Ingenierie Mol & Biochim Pharmacol, Inst Jean Barriol, FR CNRS 2843, F-57070 Metz, France
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 19期
关键词：
Cdc25; phosphatases; Coumarins; Chalcones; Heck coupling; CELL-GROWTH; SPECIFICITY;
D O I：
10.1016/j.bmcl.2010.07.130
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The cell division cycle 25 (Cdc25) family of proteins are dual specificity phosphatases that activate cyclin-dependent kinase (CDK) complexes, which in turn regulate progression through the cell division cycle. Overexpression of Cdc25 proteins has been reported in a wide variety of cancers; their inhibition may thus represent a novel approach for the development of anticancer therapeutics. Herein we report new coumarin-based scaffolds endowed with a selective inhibition against Cdc25A and Cdc25C, being 6a and 6d the most efficient inhibitors and worthy of further investigation as anticancer agents. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5827 / 5830
页数：4
相关论文
共 50 条
  • [1] Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases
    Evain-Bana, Emilie
    Schiavo, Lucie
    Bour, Christophe
    Lanfranchi, Don Antoine
    Berardozzi, Simone
    Ghirga, Francesca
    Bagrel, Denyse
    Botta, Bruno
    Hanquet, Gilles
    Mori, Mattia
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) : 113 - 118
  • [2] Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases
    Huang, WG
    Li, JY
    Zhang, W
    Zhou, YY
    Xie, CM
    Luo, Y
    Li, YF
    Wang, JL
    Li, J
    Lu, W
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1905 - 1908
  • [3] Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity
    Brun, MP
    Braud, E
    Angotti, D
    Mondésert, O
    Quaranta, M
    Montes, M
    Miteva, M
    Gresh, N
    Ducommun, B
    Garbay, C
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (16) : 4871 - 4879
  • [4] Flexibility and inhibitor binding in Cdc25 phosphatases
    Arantes, Guilherme Menegon
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2010, 78 (14) : 3017 - 3032
  • [5] Medicinal chemistry insights into novel CDC25 inhibitors
    Tao, Yucen
    Hao, Xia
    Ding, Xiao
    Cherukupalli, Srinivasulu
    Song, Yuning
    Liu, Xinyong
    Zhan, Peng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 201
  • [6] Synthesis of tanshinoneⅡA analogues and their inhibitory activities against Cdc25 phosphatases
    Wei Gang Huang~b
    Chinese Chemical Letters, 2009, 20 (12) : 1461 - 1464
  • [7] Involvment of CDC25 phosphatases in growth control.
    Davezac, N
    Ducommun, B
    Baldin, V
    PATHOLOGIE BIOLOGIE, 2000, 48 (03): : 182 - 189
  • [8] Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors
    Park, Hwangseo
    Bahn, Young Jae
    Ryu, Seong Eon
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4330 - 4334
  • [9] Synthesis of tanshinone IIA analogues and their inhibitory activities against Cdc25 phosphatases
    Huang, Wei Gang
    Li, Jing Ya
    Luo, Yu
    Li, Jia
    Lu, Wei
    CHINESE CHEMICAL LETTERS, 2009, 20 (12) : 1461 - 1464
  • [10] What's new on CDC25 phosphatase inhibitors
    Contour-Galcera, Marie-Odile
    Sidhu, Alban
    Prevost, Gregoire
    Bigg, Dennis
    Ducommun, Bernard
    PHARMACOLOGY & THERAPEUTICS, 2007, 115 (01) : 1 - 12
12345